Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial - Peng, Linyi; Nie, Yuxue; Zhou, Jiaxin; Wu, Lijun; Chen, Xiaomei; Wang, Fang; Li, Jieqiong; Peng, Yu; Lu, Hui; Zhao, Lidan; Li, Mengtao; Zhao, Yan; et al. (Annals of the rheumatic diseases, 2024)
Keywords: Disease; Glucocorticoids; Glucocorticoids - therapeutic use; Humans; IgG4 related disease; Immune System Diseases; Immunoglobulin G; Immunoglobulin G4-Related Disease - drug therapy; Immunosuppressive agents; Immunosuppressive Agents - therapeutic use; Patients; Recurrence; Remission Induction; Rheumatology; Steroid hormones; Therapeutics; Treatment Outcome; Glucocorticoids; Immune System Diseases; Therapeutics